Oncolytics Biotech (ONCY) Reports In-Line Q2 EPS

Oncolytics Biotech (NASDAQ: ONCY) reported Q2 EPS of ($0.10), in-line with the analyst estimate of ($0.10).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
• NIO delivers 35,836 vehicles in August, up 14.5% year-over-year
• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short